Evidence map›Paper›PMID 35712520›Full record

ArticleFrontiers in oncology2022

Colorectal Cancer Screening With High Risk-Factor Questionnaire and Fecal Immunochemical Tests Among 5, 947, 986 Asymptomatic Population: A Population-Based Study.

Mingqing Zhang, Lizhong Zhao, Yongdan Zhang, Haoren Jing, Lianbo Wei, Zhixuan Li, Haixiang Zhang, Yong Zhang, Siwei Zhu, Shiwu Zhang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Mingqing ZhangNankai University School of Medicine, Nankai University, Tianjin, China.
Lizhong ZhaoDepartment of Colorectal Surgery, Tianjin Union Medical Center, Tianjin, China.
Yongdan ZhangDepartment of Colorectal Surgery, Tianjin Union Medical Center, Tianjin, China.
Haoren JingDepartment of Colorectal Surgery, Tianjin Union Medical Center, Tianjin, China.
Lianbo WeiCenter for Applied Mathematics, Tianjin University, Tianjin, China.
Zhixuan LiCenter for Applied Mathematics, Tianjin University, Tianjin, China.
Haixiang ZhangCenter for Applied Mathematics, Tianjin University, Tianjin, China.
Yong ZhangCenter for Applied Mathematics, Tianjin University, Tianjin, China.
Siwei ZhuNankai University School of Medicine, Nankai University, Tianjin, China.
Shiwu ZhangThe Institute of Translational Medicine, Tianjin Union Medical Center of Nankai University, Tianjin, China.
Xipeng ZhangDepartment of Colorectal Surgery, Tianjin Union Medical Center, Tianjin, China.
Tianjin People's Hospital · CNTianjin University · CNNankai University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The recent uptrend in colorectal cancer (CRC) incidence in China is causing an increasingly overwhelming social burden. And its occurrence can be effectively reduced by sensitizing CRC screening for early diagnosis and treatment. However, a large number of people in China do not undergo screening due to multiple factors. To address this issue, since 2012, a CRC screening program has been initiated in Tianjin. Methods: Residents aged 40-74 years were eligible for CRC screening. The first was to complete the high-risk factor questionnaire (HRFQ) and undergo fecal immunochemical test (FIT). Then those with a positive result in any of the two screening methods were recommended for a free colonoscopy. Results: The detection rate of intestinal diseases increased with age, had a male predominance, and was higher in residents from central urban areas and those with primary school above education level. The sensitivity of predicting CRC after colonoscopy in the high-risk group was 76.02%; the specificity was 25.33%.A significant decrease in the detection rate of intestinal disease, CRC and advanced adenoma was observed from positive FIT, the high-risk group and positive HRFQ, 47.13%, 44.79%, 42.30%; 3.15%, 2.44%, 1.76%; 7.72%, 6.42%, 5.08%, in that order, while no inter-group difference was found for the detection of polyps. In addition, the different combinations of HRFQ and FIT can enroll more high-risk population than FIT or (and) HRFQ only, and thus detect more intestinal diseases (include CRC/AA/Polyp). Conclusion: The superimposition of different screening method for HRFQ and FIT is an effective strategy for the detection of CRC, AA, and Polyp, compared to HRFQ or FIT alone. However, further improvements in screening and interventions are needed to promote colonoscopy compliance.

Indexed as

asymptomatic populationcolonoscopycolorectal cancer screeningfecal immunochemical testhigh-risk factor questionnaire

Identifiers

PMID35712520
PMCPMC9195590
OpenAlexW4281968179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.